Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

9 treatments under study, led by Unicorn Robotic Bronchoscopy System

Research Leaders

12 sponsors active, led by Shanghai Chest Hospital

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (3)

Trial Status

Recruiting1
Not Yet Recruiting1
Unknown1
Active Not Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (5)

Research Network

Common Treatments

  • Unicorn Robotic Bronchoscopy System1
  • Virtual Bronchoscopic Navigation Combined With Endobronchial Ultrasound1
  • Conventional Navigation Bronchoscopy1
  • Bronchoscopic Transparenchymal Nodule Access1
  • Guide Sheath1

Active Sponsors

  • Shanghai Chest Hospital2
  • West China Hospital2
  • Guangzhou Medical University2
  • Henan Provincial People's Hospital2
  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences1

Top Investigators

Related Conditions

  • Lung Nodule Solitary1

Activity Timeline